Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogénétique Hématologique study

Autor: Coyaud, Etienne ^*, Struski, Stephanie ^*, Prade, Nais, Familiades, Julien, Eichner, Ruth, Quelen, Cathy, Bousquet, Marina, Mugneret, Francine, Talmant, Pascaline, Pages, Marie-Pierre, Lefebvre, Christine, Penther, Dominique, Lippert, Eric, Nadal, Nathalie, Taviaux, Sylvie, Poppe, Bruce, Luquet, Isabelle, Baranger, Laurence, Eclache, Virginie, Radford, Isabelle, Barin, Carole, Mozziconacci, Marie-Joëlle, Lafage-Pochitaloff, Marina, Antoine-Poirel, Hélène, Charrin, Christiane, Perot, Christine, Terre, Christine, Brousset, Pierre, Dastugue, Nicole, Broccardo, Cyril

Publikováno v: In Blood 15 April 2010 115(15):3089-3097

Key contribution of eIF4H-mediated translational control in tumor promotion

Autor: Vaysse, Charlotte, Philippe, Celine, Yvan Martineau, Quelen, Cathy, Hieblot, Corinne, Renaud, Claire, Nicaise, Yvan, Desquesnes, Aurore, Pannese, Maria, Filleron, Thomas, Escourrou, Ghislaine, Lawson, Malcolm, Rintoul, Robert C., Delisle, Marie Bernadette, Pyronnet, Stephane, Brousset, Pierre, Prats, Herve, Touriol, Christian

Publikováno v: Oncotarget
ResearcherID

Dysregulated expression of translation initiation factors has been associated with carcinogenesis, but underlying mechanisms remains to be fully understood. Here we show that eIF4H (eukaryotic translation initiation factor 4H), an activator of the RN

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58fc1085d81aea13f687dedd775523d8

The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene.

Autor: Bousquet, Marina¹, Quelen, Cathy¹, De Mas, Véronique¹, Duchayne, Eliane¹, Roquefeuil, Blandine¹, Delsol, Georges¹, Laurent, Guy¹, Dastugue, Nicole¹, Brousset, Pierre¹ brousset.p@chu-toulouse.fr

Publikováno v: Oncogene. 11/3/2005, Vol. 24 Issue 48, p7248-7252. 5p. 1 Color Photograph, 1 Black and White Photograph.

Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth

Autor: Hoareau-Aveilla, Coralie, Valentin, Thibaud, Daugrois, Camille, Quelen, Cathy, Mitou, Géraldine, Quentin, Samuel, Jia, Jinsong, Spicuglia, Salvatore, Ferrier, Pierre, Ceccon, Monica, Giuriato, Sylvie, Gambacorti-Passerini, Carlo, Brousset, Pierre, Lamant, Laurence, Meggetto, Fabienne

Publikováno v: Journal of Clinical Investigation
Journal of Clinical Investigation, American Society for Clinical Investigation, 2015, 125 (9), pp.3505--3518. ⟨10.1172/JCI78488⟩
Journal of Clinical Investigation, 2015, 125 (9), pp.3505--3518. ⟨10.1172/JCI78488⟩

The regulatory microRNA miR-150 is involved in the development of hemopathies and is downregulated in T-lymphomas, such as anaplastic large-cell lymphoma (ALCL) tumors. ALCL is defined by the presence or absence of translocations that activate the an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::77af2683631bf8f548aa8c2fc9d9a06c
https://hal-amu.archives-ouvertes.fr/hal-01614947